This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PDL BioPharma Inc (PDLI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 218.88M 291.38M 94.30M 131.21M
Receivables 58.40M 57.90M 313.00K 7.87M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 282.71M 355.90M 107.70M 182.99M
Property, Plant & Equipment, Gross 9.18M 9.24M 9.19M 9.19M
Accumulated Depreciation & Depletion 9.15M 9.18M 9.15M 9.13M
Property, Plant & Equipment, Net 31.00K 62.00K 41.00K 59.00K
Intangibles 399.20M 259.24M 235.68M 0.00
Other Non-Current Assets 318.06M 313.35M 193.84M 92.37M
Total Non-Current Assets 733.47M 606.45M 436.26M 96.98M
Liabilities & Shareholder Equity
Total Assets 1.02B 962.35M 543.96M 279.97M
Accounts Payable 394.00K 318.00K 287.00K 1.07M
Short Term Debt 24.97M 0.00 74.40M 0.00
Other Current Liabilities 3.56M 4.33M 59.00K 287.00K
Total Current Liabilities 36.74M 187.98M 407.42M 10.47M
Long Term Debt 232.84M 276.23M 0.00 309.95M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 50.65M 37.70M 23.04M 27.66M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 283.49M 313.93M 23.04M 337.61M
Total Liabilities 320.23M 501.91M 430.47M 348.09M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 695.95M 460.44M 113.49M -68.12M
Common Par 1.64M 1.62M 1.40M 1.40M
Additional Paid In Capital -117.98M -119.87M -233.17M -234.07M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 810.04M 575.74M 350.15M 169.63M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 2.26M 2.95M -4.89M -5.09M
Total Capitalization 928.79M 736.66M 113.49M 241.83M
Total Equity 695.95M 460.44M 113.49M -68.12M
Total Liabilities & Stock Equity 1.02B 962.35M 543.96M 279.97M
Total Common Shares Outstanding 164.29M 162.19M 139.94M 139.82M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 163.39M 158.22M 139.84M 139.71M
Diluted Weighted Shares Outstanding 163.55M 173.11M 159.34M 146.40M
Number of Employees 10 10 10 10
Number of Part-Time Employees 0 0 0 0
PDLI News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PDLI PDL BioPharma Inc

Chart of PDLI

Analysts Ratings for PDLI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PDLI ANALYST REPORT

PDLI Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs